ESR1 and essential thrombocythemia: Recent studies suggest that the C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-α [37] may serve as a molecular mechanism for the critical therapeutic window for post-menopausal ET [37], [38].